Skip to main content
Quest Diagnostics

Case study: Commercializing rare disease treatment

Delivering insights to help optimize sales and marketing outreach

This case study highlights how Quest Diagnostics helped a pharmaceutical company to support the commercialization of a rare blood disorder drug using near real-time lab data. By delivering daily alerts on relevant test orders and results, Quest enabled the company’s sales team to identify and engage physicians during critical decision-making windows.

Download the case study to learn how Quest Commercial Alerts helped to identify physicians with potentially eligible patients for a rare blood disorder drug and how many physician alerts were provided over a 12-month period.

Let's discuss collaborative opportunities to bring new treatments to patients faster. Let's talk!

827

* indicates required

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.